Board of Advisors

LSC    Boston    Join 

Our Board of Advisors, all industry leaders, have made a powerful statement by supporting Life Science Cares and our goal to end poverty in our community. Our Advisors make a personal financial contribution annually to cover LSC’s administrative costs, allowing us to channel money raised from our events, Corporate Membership contributions, and donations from other  individuals to our partner organizations.

Our Board of Advisor members also choose to volunteer with their companies and recruit their colleagues to join in this collective effort.

BOSTON BOARD OF ADVISORS

ABCDEFGHIJKLMNOPQRSTUVWXYZ
Jeff Albers

Jeff Albers

CEO

Blueprint Medicines

Rich Aldrich

Rich Aldrich

General Partner

Longwood Fund

Pat Andrews

Pat Andrews

CEO

Sumitomo Dainippon Pharma Oncology

Tom Andrews

Tom Andrews

Executive Vice President

Alexandria Real Estate Equities, Inc.

Imran Babar

Imran Babar

Chief Business Officer

Cydan II Inc.

Mark Bamforth

Mark Bamforth

President & CEO

Arranta Bio

Stephane Bancel

Stephane Bancel

CEO

Moderna Therapeutics

Peter Barrett

Peter Barrett

Partner

Atlas Venture

Russell Bartlett

Russell Bartlett

Vice President

Alex Brown

Marc Beer

Marc Beer

CEO

Renovia

Kevin Bitterman

Kevin Bitterman

Partner

Atlas Venture

Mitch Bloom

Mitch Bloom

Partner

Goodwin

Joshua Boger

Joshua Boger

Foundation & CEO (Former)

Vertex Pharmaceuticals

Mike Bonney

Mike Bonney

Executive Chair

Kaleido Biosciences

Bruce Booth

Bruce Booth

Partner

Atlas Venture

Katrine Bosley

Katrine Bosley

Chairman of the Board

Arrakis Therapeutics

Michael Broxson

Michael Broxson

CEO

Q32 Bio

Gerry Brunk

Gerry Brunk

Managing Director

Lumira VC

Paul Burgess

Paul Burgess

Chief Legal Officer & Chief Operating Officer

Translate Bio

Stuart Cable

Stuart Cable

Partner

Goodwin

Pablo Cagnoni

Pablo Cagnoni

CEO

Rubius Therapeutics

Thomas Carey

Thomas Carey

Founder & Managing Partner

Perspective Group

Abe Ceesay

Abe Ceesay

CEO

Tiburio Therapeutics

Abbie Celniker

Abbie Celniker

Partner

Third Rock Ventures

Scott Chamberlin

Scott Chamberlin

Senior Vice President & Head of Innovation Banking

Cambridge Trust

Bharatt Chowrira

Bharatt Chowrira

President

PureTech Health

Tim Clackson

Tim Clackson

President & Chief Technology Officer

Xilio Therapeutics

Paul Clancy

Paul Clancy

Executive Vice President (Former)

Alexion

Chip Clark

Chip Clark

President & CEO

Genocea

Hugh Cole

Hugh Cole

Chief Business Officer & Head of Corporate Development

Jounce Therapeutics

Tony Coles

Tony Coles

CEO

Cerevel Therapeutics

Ron Cooper

Ron Cooper

President & CEO

Albireo Pharma

Bob Coughlin

Bob Coughlin

President & CEO

MassBio

Zoltan Csimma

Zoltan Csimma

Senior Biotech Executive

Elisabet De los Pinos

Elisabet De los Pinos

CEO

Aura Biosciences

Dee Dee DeMan

Dee Dee DeMan

Chairman & CEO

Bench International

Tom DesRosier

Tom DesRosier

Executive Vice President & Chief Legal Officer

Seres Therapeutics

Steven Dickman

Steven Dickman

Owner

CBT Advisors

Michelle Dipp

Michelle Dipp

Co-Founder and Managing Partner

Biospring Partners

Ed Downey

Ed Downey

Principal

Plimouth Rock Risk Consulting

Neal Dunn

Neal Dunn

Partner

Trinity

Tim Ehrlich

Tim Ehrlich

Partner

Gunderson Dettmer Stough Villeneuve Franklin

Paul Enderle

Paul Enderle

Managing Director

Baycross Capital Group

Wendy Erler

Wendy Erler

VP, Head of STAR Patient Insights & Advocacy

Greg Erman

Greg Erman

CEO

EmpiraMed

Elan Ezickson

Elan Ezickson

Founding CEO

Sporos Bioventures

Douglas Fambrough

Douglas Fambrough

CEO

Dicerna

Joe Farmer

Joe Farmer

Chief Operating Officer

Xilio Therapeutics

Ali Fattaey

Ali Fattaey

CEO

MetaboMed

Robert Forrester

Robert Forrester

Co-Founder & CXO

EQRx

James Foster

James Foster

Chairman, President & CEO

Charles River Labs

Chris Gabrieli

Chris Gabrieli

Biotech VC (Retired)

Nick Galakatos

Nick Galakatos

Senior Managing Director

Blackstone

Daniel Geffken

Daniel Geffken

Managing Director

Danforth Advisors

Jean George

Jean George

General Partner

Lightstone Ventures

Jim Geraghty

Jim Geraghty

Experienced Board Director & Chair

Halley Gilbert

Halley Gilbert

Chief Operating Officer & Chief Business Officer

Adagio Therapeutics

Michael Gilman

Michael Gilman

CEO

Arrakis Therapeutics

Glen Giovannetti

Glen Giovannetti

Global Biotechnology Leader (Retired)

EY

John Glasspool

John Glasspool

CEO

Anthos Therapeutics

Jeff Goater

Jeff Goater

CEO

Surface Oncology

Brian Goff

Brian Goff

Chief Commercial and Global Operations Officer

Alexion

Kurt Graves

Kurt Graves

Chairman, President & CEO

Intarcia

Mike Gray

Mike Gray

Chief Financial & Chief Operating Officer

Imara Therapeutics

Dave Grayzel

Dave Grayzel

Partner

Atlas Venture

Adam Gridley

Adam Gridley

CEO

Foundry Therapeutics 1

Chris Guiffre

Chris Guiffre

Chief Financial & Chief Operating Officer

Pear Therapeutics

Penny Heaton

Penny Heaton

CEO

Bill & Melinda Gates Medical Research Institute

Michael Heffernan

Michael Heffernan

Chairman

Collegium Pharmaceuticals

Bill Heiden

Bill Heiden

Healthcare Executive & Board Member

Jeffrey Hemman

Jeffrey Hemman

Partner

PWC

Bill Hicks

Bill Hicks

Partner

Mintz

Donna Higgins

Donna Higgins

President & CEO

The Higgins Group

Colin Hill

Colin Hill

CEO, Chairman & Co-Founder

GNS Healthcare

Andrew Hirsch

Andrew Hirsch

CEO

C4 Therapeutics

Roy Hirshland

Roy Hirshland

CEO & Co-Founder

T3 Advisors

Maura Hodge

Maura Hodge

Partner

KPMG

Tim Hunt

Tim Hunt

Senior Vice President, Corporate Affairs (Former)

Editas Medicine

Trish Hurter

Trish Hurter

CEO & President

Lyndra Therapeutics

Doug Ingram

Doug Ingram

CEO

Sarepta

Bruce Jacobs

Bruce Jacobs

Chief Financial Officer

Kymera Therapeutics

Pierre Jacquet

Pierre Jacquet

Managing Director & Partner

L.E.K. Consulting

Brian Johnson

Brian Johnson

President

MassMEDIC

Rosanna Kapeller

Rosanna Kapeller

President & CEO

Rome Therapeutics

Ed Kaye, MD

Ed Kaye, MD

CEO & Director

Stoke Therapeutics

Jeb Keiper

Jeb Keiper

CEO

Nimbus Therapeutics

Jason Kelly

Jason Kelly

CEO

Ginkgo Bio

Skip Kelly

Skip Kelly

Managing Director, Middle Market Banking & Specialized Industries, J.P. Morgan Commercial Banking

JP Morgan

Richard Kertzman

Richard Kertzman

Managing Director

First Republic Bank

Iya Khalil

Iya Khalil

Global Head of the AI Innovation Center

Novartis

Eric Kimble

Eric Kimble

Chief Commercial Officer

Adagio Therapeutics

Bjorn Koch

Bjorn Koch

Senior Vice President, Wealth Management

UBS

Adam Koppel

Adam Koppel

Managing Director

Bain Capital Life Sciences

Joanne Kotz

Joanne Kotz

President & CEO

Jnana Therapeutics

Nerissa Kreher

Nerissa Kreher

Chief Medical Offficer

Entrada Therapeutics

Michel Lagarde

Michel Lagarde

Executive Vice President

Thermo Fisher Scientific

Peter Latham

Peter Latham

CEO

Latham Biopharma Group

Donna Lavoie

Donna Lavoie

CEO

LavoieHealthScience

Alison  Lawton

Alison Lawton

Special Advisor to the CEO

Kaleido Biosciences

Jeff Leerink

Jeff Leerink

CEO

SVB Leerink

Jeff Leiden

Jeff Leiden

Executive Chairman

Vertex Pharmaceuticals

Rami Levin

Rami Levin

CEO

Saniona

Mark Levin

Mark Levin

Partner

Third Rock Ventures

David Lucchino

David Lucchino

CEO

Frequency Therapeutics

Daniel Lynch

Daniel Lynch

Chairman

bluebird bio

Greg Madison

Greg Madison

CEO

Melt Pharmaceuticals

Ivana Magovcevic-Liebisch

Ivana Magovcevic-Liebisch

President & CEO

Vigil Neuroscience

Michael Maguire

Michael Maguire

Healthcare Analyst

Putnam Investments

Ankit Mahadevia

Ankit Mahadevia

CEO

Spero Therapeutics

Hilary Malone

Hilary Malone

Chief Operating Officer

Valo Health

John Maraganore

John Maraganore

CEO

Alnylam

Eddie Martucci

Eddie Martucci

CEO

Akili Interactive

Cynthia Mazareas

Cynthia Mazareas

Partner

WilmerHale

Katie McCarthy

Katie McCarthy

Managing Director

Halloran Consulting Group

Travis McCready

Travis McCready

Executive Director/National Practice Leader

JLL

Geoffrey McDonough

Geoffrey McDonough

President & CEO

Generation Bio

Bill McVicar

Bill McVicar

Principal Consultant

BioStrat Consulting

David Meek

David Meek

President & CEO

FerGene

David Meeker

David Meeker

President & CEO

Rhythm Pharmaceuticals

Dave Mello

Dave Mello

President

The Richmond Group

David  Melville

David Melville

CEO

The Bowdoin Group

Jill Milne

Jill Milne

President & CEO

Catabasis Pharmaceuticals

Jodie Morrison

Jodie Morrison

CEO

Cadent Therapeutics

Cherie Myatt

Cherie Myatt

Owner & Founder

The CM Group

Ted Myles

Ted Myles

Chief Financial Officer & Head of Business Operations

Scholar Rock

Marian Nakada

Marian Nakada

Vice President, Venture Investments

J&J

Amir Nashat

Amir Nashat

Partner

Polaris Partners

Susan Nemetz

Susan Nemetz

Principal

The NemetzGroup

Allen Nunnally

Allen Nunnally

Chief Business Officer

Voyager Therapeutics

Susan O'Connor

Susan O'Connor

Chief Human Resources Officer

Beam Therapeutics

Mike O'Hara

Mike O'Hara

Partner

Deloitte

Leslie Orne

Leslie Orne

Senior Partner

Trinity

Douglas Pagan

Douglas Pagan

Chief Financial Officer

Dicerna

Paris Panayiotopoulos

Paris Panayiotopoulos

Senior Managing Director

The Blackstone Group

Kush Parmar

Kush Parmar

Managing Partner

5AM Ventures

Deval Patrick

Deval Patrick

Founder & Chairman

TogetherFUND

Richard Paulson

Richard Paulson

CEO, North America

Ipsen

Peter Pedro

Peter Pedro

Executive Vice President

Marsh & McLennan Agency

Brian Pereira

Brian Pereira

CEO

Visterra

Rob Perez

Rob Perez

Operating Partner

General Atlantic

Adelene Perkins

Adelene Perkins

President & CEO

Infinity Pharmaceuticals

Paula Ragan

Paula Ragan

CEO & President

X4 Pharmaceuticals

Jigar Raythatha

Jigar Raythatha

CEO

Constellation Pharma

Laurence Reid

Laurence Reid

CEO

Decibel Therapeutics

Jason Rhodes

Jason Rhodes

Partner

Atlas Venture

Rene Russo

Rene Russo

CEO

Xilio Therapeutics

Tracey Sacco

Tracey Sacco

Senior Vice President, Global Marketing and Alliance Management

Acceleron Pharma

Nabiha Saklayen

Nabiha Saklayen

Co-Founder & CEO

Cellino Biotech

Ian Sanderson

Ian Sanderson

Chief Financial Officer

Boston Pharmaceuticals

Alicia Secor

Alicia Secor

President & CEO

Atalanta Therapeutics

Eric Shaff

Eric Shaff

President & CEO

Seres Therapeutics

Bill Sibold

Bill Sibold

Senior Vice President

Sanofi Genzyme

Nancy Simonian

Nancy Simonian

CEO

Syros Pharmaceuticals

Otello Stampacchia

Otello Stampacchia

Founder

Omega Funds

Mary Thistle

Mary Thistle

Special Advisor

Bill & Melinda Gates Medical Research Institute

Frank Thomas

Frank Thomas

Chief Financial Officer & Chief Business Officer

Orchard Therapeutics

Timothy Thompson

Timothy Thompson

Healthcare Technology Executive

Praveen Tipirneni

Praveen Tipirneni

CEO

Morphic Therapeutic

Mike Tomsicek

Mike Tomsicek

Chief Financial Officer

CRISPR Therapeutics

Jose Trevejo

Jose Trevejo

Chief Development Officer

Rocket Pharmaceuticals

Samantha Truex

Samantha Truex

CEO

Quench Bio

Robert Urban

Robert Urban

Global Head (Former/Retired)

J&J Innovation

Rajeev Venkayya

Rajeev Venkayya

President, Global Vaccines Business Unite

Takeda

Jo Viney

Jo Viney

Co-Founder, President & CSO

Pandion Therapeutics

Shelia Violette

Shelia Violette

Co-Founder, Chief Scientific Officer & President of Research

Q32 Bio

Joseph Vittiglio

Joseph Vittiglio

Executive Vice President & General Counsel

AMAG Pharmaceuticals

Joe vonRickenbach

Joe vonRickenbach

Co-Founder & Chairman

Parexel

Michel Vounatsos

Michel Vounatsos

CEO

Biogen

Elizabeth Wagner

Elizabeth Wagner

Chief Operating Officer

Constant Pharmaceuticals

Kate Walsh

Kate Walsh

Managing Director, Life Science & Healthcare

Silicon Valley Bank

Christoph Westphal

Christoph Westphal

General Partner

Longwood Fund

Leslie Williams

Leslie Williams

Board Member

Ocular Therapeutix

Cissy Young

Cissy Young

Chief People Officer

Valo Health